133 related articles for article (PubMed ID: 17194528)
1. Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence.
Ye B; Aponte M; Dai Y; Li L; Ho MC; Vitonis A; Edwards D; Huang TN; Cramer DW
Cancer Lett; 2007 Jun; 251(1):43-52. PubMed ID: 17194528
[TBL] [Abstract][Full Text] [Related]
2. Effect of ginkgolide B on striatal extracellular amino acids in middle cerebral artery occluded rats.
Yang ZZ; Li J; Li SX; Feng W; Wang H
J Ethnopharmacol; 2011 Jun; 136(1):117-22. PubMed ID: 21527331
[TBL] [Abstract][Full Text] [Related]
3. Ginkgo May Sensitize Ovarian Cancer Cells to Cisplatin: Antiproliferative and Apoptosis-Inducing Effects of Ginkgolide B on Ovarian Cancer Cells.
Jiang W; Cong Q; Wang Y; Ye B; Xu C
Integr Cancer Ther; 2014 May; 13(3):NP10-7. PubMed ID: 22505596
[TBL] [Abstract][Full Text] [Related]
4. Ginkgo may prevent genetic-associated ovarian cancer risk: multiple biomarkers and anticancer pathways induced by ginkgolide B in BRCA1-mutant ovarian epithelial cells.
Jiang W; Qiu W; Wang Y; Cong Q; Edwards D; Ye B; Xu C
Eur J Cancer Prev; 2011 Nov; 20(6):508-17. PubMed ID: 21857521
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against beta-amyloid peptide-induced toxicity in SH-SY5Y cells.
Shi C; Zhao L; Zhu B; Li Q; Yew DT; Yao Z; Xu J
Chem Biol Interact; 2009 Sep; 181(1):115-23. PubMed ID: 19464278
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography-atmospheric pressure chemical ionisation/mass spectrometry: a rapid and selective method for the quantitative determination of ginkgolides and bilobalide in ginkgo leaf extracts and phytopharmaceuticals.
Jensen AG; Ndjoko K; Wolfender JL; Hostettmann K; Camponovo F; Soldati F
Phytochem Anal; 2002; 13(1):31-8. PubMed ID: 11899603
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.
Ahlemeyer B; Krieglstein J
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S8-14. PubMed ID: 13130383
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of STAT3 activation cascade by Ginkgolide C mitigates tumourigenesis in lung cancer preclinical model.
Yang MH; Ha IJ; Lee SG; Um JY; Ahn KS
J Pharm Pharmacol; 2021 Dec; 73(12):1630-1642. PubMed ID: 34559878
[TBL] [Abstract][Full Text] [Related]
9. Determination of ginkgolide A, B, and bilobalide in biloba L. extracts by microdialysis-HPLC.
Chiu HL; Lin HY; Yang TC
Anal Bioanal Chem; 2004 Jun; 379(3):445-8. PubMed ID: 15057504
[TBL] [Abstract][Full Text] [Related]
10. Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations.
Kressmann S; Biber A; Wonnemann M; Schug B; Blume HH; Müller WE
J Pharm Pharmacol; 2002 Nov; 54(11):1507-14. PubMed ID: 12495553
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of ginkgolides A, B, C and bilobalide in plasma by LC-MS/MS and its application to the pharmacokinetic study of Ginkgo biloba extract in rats.
Xie J; Ding C; Ge Q; Zhou Z; Zhi X
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Mar; 864(1-2):87-94. PubMed ID: 18295555
[TBL] [Abstract][Full Text] [Related]
12. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats.
Guan H; Qian D; Ren H; Zhang W; Nie H; Shang E; Duan J
J Ethnopharmacol; 2014 Aug; 155(1):758-68. PubMed ID: 24953034
[TBL] [Abstract][Full Text] [Related]
13. Discovery of unreported ginkgolides of anti-PAF activity using characteristic ion and neutral loss recognition strategy in Ginkgo biloba L.
Zhang J; Cheng J; Yan L; Yu Y; Hao C; Zhao A; Chen S; Liu A
Phytochemistry; 2022 Nov; 203():113355. PubMed ID: 35948139
[TBL] [Abstract][Full Text] [Related]
14. Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2013 Mar; (578):1-183. PubMed ID: 23652021
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.
Lau AJ; Chang TK
Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249
[TBL] [Abstract][Full Text] [Related]
16. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols.
Kuo If; Chen J; Chang TK
Can J Physiol Pharmacol; 2004 Jan; 82(1):57-64. PubMed ID: 15052306
[TBL] [Abstract][Full Text] [Related]
17. Preparation of a new component group of Ginkgo biloba leaves and investigation of the antihypertensive effects in spontaneously hypertensive rats.
Liang H; Yuan X; Sun C; Sun Y; Yang M; Feng S; Yao J; Liu Z; Zhang G; Li F
Biomed Pharmacother; 2022 May; 149():112805. PubMed ID: 35276465
[TBL] [Abstract][Full Text] [Related]
18. Liquid chromatography/electrospray mass spectrometry of bioactive terpenoids in Ginkgo biloba L.
Mauri P; Migliazza B; Pietta P
J Mass Spectrom; 1999 Dec; 34(12):1361-7. PubMed ID: 10587633
[TBL] [Abstract][Full Text] [Related]
19. Potential effets of ginkgo (Ginkgo biloba, L.) on female reproduction.
Sirotkin AV
Reprod Biol; 2021 Dec; 21(4):100568. PubMed ID: 34656881
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of ginkgolides and bilobalide from extracts of ginkgo biloba using GC/MS.
Biber A; Koch E
Planta Med; 1999 Mar; 65(2):192-3. PubMed ID: 10193211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
